Bunkerhill Abdominal Aortic Quantification (AAQ) vs ZEUS System

Similar category, different focus. These tools serve overlapping but distinct needs. Comparability 60/100 Comparability is an AI-graded 0–100 score of how directly these two tools compete — higher means a more apples-to-apples comparison.
VS
by iRhythm Technologies

AI Verdict

These tools address distinct areas within cardiology. Bunkerhill Abdominal Aortic Quantification (AAQ) is designed for automated quantification and detection of abdominal aortic aneurysms using CT scans, focusing on structural cardiovascular health. In contrast, the ZEUS System specializes in the AI-powered detection and characterization of cardiac arrhythmias, such as Atrial Fibrillation, through continuous ECG monitoring from wearable biosensors.

Choose Bunkerhill Abdominal Aortic Quantification (AAQ) if…

Choose Bunkerhill Abdominal Aortic Quantification (AAQ) if your institution requires automated, AI-driven analysis of contrast and non-contrast CT scans for early and opportunistic detection of abdominal aortic aneurysms. This tool is ideal for streamlining follow-up workflows, ensuring guideline-based surveillance, and integrating seamlessly with EHRs to automate subsequent clinical actions for at-risk patients.

View Bunkerhill Abdominal Aortic Quantification (AAQ) →

Choose ZEUS System if…

Choose the ZEUS System if your practice focuses on long-term, continuous cardiac monitoring using wearable biosensors to detect and characterize arrhythmias like Atrial Fibrillation. This AI-powered solution is best suited for identifying both symptomatic and asymptomatic cardiac events over an extended period, providing preliminary reports to aid in timely diagnosis and management.

View ZEUS System →

Reviewed by Pouyan Golshani, MD — Interventional Radiologist

Quick Comparison

Feature Bunkerhill Abdominal Aortic Quantification (AAQ) ZEUS System
Pricing Contact for pricing Not disclosed
Deployment Cloud-based (utilizes AWS for cloud infrastructure) Cloud-based (AWS EC2 platform), no on-premise hardware.
FDA Status Yes AI-estimated 1 AI-estimated
HIPAA Yes AI-estimated Unknown

Head-to-Head

AI-generated assessment across six dimensions based on each tool's documented features and compliance posture. Grounded in public data — not a substitute for hands-on evaluation.

Usability

ZEUS System

Tool B (ZEUS System) offers a patient-friendly wearable design that is easy to apply and wear, which significantly enhances patient compliance and data collection. For clinicians, its ZioSuite portal and app provide intuitive tools for report interpretation and patient management, supported by clear instructions for use.

Clinical Value

ZEUS System

While both tools offer significant clinical value, Tool B (ZEUS System) has a more extensive body of published clinical evidence and health economic analyses. Studies demonstrate its superiority over traditional methods in detecting arrhythmias, leading to improved diagnostic yield, better quality-adjusted survival, and reduced healthcare utilization for conditions like AFib.

Pricing & Value

ZEUS System

Tool B (ZEUS System) provides greater transparency regarding its value proposition through published cost-effectiveness studies and established reimbursement pathways with major insurance providers and Medicare. It also offers patient financial assistance programs. Tool A's pricing is custom and requires direct contact, with less public data on its economic value, though it recently secured a CMS reimbursement pathway.

Enterprise Readiness

ZEUS System

Tool B (ZEUS System) demonstrates superior enterprise readiness with a broader array of certifications, including SOC 2 Type II, FIPS 140-2, ISO 13485, and Joint Commission Gold Seal, alongside compliance with international data regulations like GDPR and CCPA. It also has proven EHR integration with a large customer base and has invested in manufacturing automation for scalability.

Innovation

Bunkerhill Abdominal Aortic Quantification (AAQ)

Tool A (Bunkerhill AAQ) stands out for its explicit claim of being the 'first FDA-cleared AI' for abdominal aortic diameter quantification and its broader application of 'generative AI for clinical reasoning and action' across structured and unstructured patient data. Its focus on opportunistic screening for various conditions from routine imaging, including recent FDA clearances for mitral annular calcification and bone density, represents a more cutting-edge and expansive innovative approach.

Support & Docs

ZEUS System

Tool B (ZEUS System) provides comprehensive support and documentation, including 24/7 customer care, patient-facing apps with educational content, clinician portals for report management, and a newly launched 'iRhythm Academy' for clinician education. This extensive ecosystem ensures users have ample resources and assistance. Tool A lacks publicly available information on this dimension.

Feature-by-Feature

Detail beyond the Quick Comparison summary. For pricing, deployment, BAA, FDA, and HIPAA see the Overview tab.

Feature Bunkerhill Abdominal Aortic Quantification (AAQ) ZEUS System
Name Bunkerhill Abdominal Aortic Quantification (AAQ) ZEUS System
Company BunkerHill Health iRhythm Technologies
Primary Clinical Focus Automates abdominal aortic diameter quantification on CT scans for early aneurysm detection and streamlined follow-up. Analyzes ECG data from wearable biosensors for long-term continuous cardiac monitoring, aiding in arrhythmia detection.
Key Data Source Contrast and non-contrast CT scans ECG data from wearable biosensors
Specific Detections/Quantifications Automated abdominal aortic diameter quantification, opportunistic screening for silent aneurysms, detection of interval growth in aortic measurements. AI-powered arrhythmia detection, detection and characterization of Atrial Fibrillation (AFib).
EHR Integration Seamless integration with Electronic Health Records (EHRs) HL7-based EHR integration

Videos

Demos, reviews, and walkthroughs featuring Bunkerhill Abdominal Aortic Quantification (AAQ) and ZEUS System.

Loading videos…
Videos need JavaScript to load. Search YouTube directly →

View all on YouTube

Frequently Asked Questions

Bunkerhill Abdominal Aortic Quantification (AAQ) is designed for automated quantification of abdominal aortic diameter on contrast and non-contrast CT scans, enabling early aneurysm detection and streamlined follow-up. The ZEUS System by iRhythm Technologies focuses on analyzing ECG data from wearable biosensors for long-term continuous cardiac monitoring, aiding in the detection and characterization of arrhythmias like Atrial Fibrillation.
Bunkerhill AAQ processes both contrast and non-contrast CT scans to quantify abdominal aortic diameters. In contrast, the ZEUS System analyzes ECG data obtained from wearable biosensors, including the Zio Watch and Zio monitors.
Bunkerhill AAQ offers seamless integration with Electronic Health Records (EHRs) and the Carebricks platform for automated follow-up workflows and appropriate next steps. The ZEUS System supports HL7-based EHR integration and integrates with Zio Watch and Zio monitors for data input and preliminary report generation.
Both Bunkerhill Abdominal Aortic Quantification (AAQ) and the ZEUS System are FDA-cleared and HIPAA compliant. Both companies also indicate having a Business Associate Agreement (BAA) in place, and the ZEUS System's infrastructure is hosted on AWS, adhering to industry best practices for data security.
Bunkerhill AAQ provides opportunistic screening for silent aneurysms from routine CTs and detects interval growth in aortic measurements. The ZEUS System offers long-term continuous ECG monitoring for up to 14 days, supporting the detection and characterization of both symptomatic and asymptomatic cardiac events.

Backers

Who funded each tool's parent company.

AI Tool Finder
AI-powered search. Results may not be comprehensive.